Prognostic implications of the expression levels of different immunoglobulin heavy chain-encoding RNAs in early breast cancer.
Breast cancer
Prognostic markers
Tumour immunology
Journal
NPJ breast cancer
ISSN: 2374-4677
Titre abrégé: NPJ Breast Cancer
Pays: United States
ID NLM: 101674891
Informations de publication
Date de publication:
2020
2020
Historique:
received:
27
05
2019
accepted:
02
06
2020
entrez:
14
7
2020
pubmed:
14
7
2020
medline:
14
7
2020
Statut:
epublish
Résumé
The extent and composition of the immune response in a breast cancer is one important prognostic factor for the disease. The aim of the current work was to refine the analysis of the humoral component of an immune response in breast tumors by quantifying mRNA expression of different immunoglobulin classes and study their association with prognosis. We used RNA-Seq data from two local population-based breast cancer cohorts to determine the expression of
Identifiants
pubmed: 32656317
doi: 10.1038/s41523-020-0170-2
pii: 170
pmc: PMC7338507
doi:
Types de publication
Journal Article
Langues
eng
Pagination
28Informations de copyright
© The Author(s) 2020.
Déclaration de conflit d'intérêts
Competing interestsThe authors declare that they have no competing interests.
Références
Nat Protoc. 2009;4(8):1184-91
pubmed: 19617889
J Clin Oncol. 2014 Sep 20;32(27):2959-66
pubmed: 25071121
Cancer Immunol Res. 2015 Apr;3(4):326-32
pubmed: 25527356
Genome Biol. 2016 Oct 20;17(1):218
pubmed: 27765066
JAMA Oncol. 2016 Jan;2(1):56-64
pubmed: 26469139
Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74
pubmed: 11553815
J Clin Oncol. 2011 May 20;29(15):1949-55
pubmed: 21483002
Genome Biol. 2013 Apr 25;14(4):R36
pubmed: 23618408
BMC Cancer. 2012 Jul 23;12:306
pubmed: 22824040
Breast Cancer Res. 2015 Feb 21;17:23
pubmed: 25848820
Breast Cancer Res. 2012 Mar 15;14(2):R48
pubmed: 22420471
Nature. 2012 Apr 18;486(7403):346-52
pubmed: 22522925
N Engl J Med. 2018 Nov 29;379(22):2108-2121
pubmed: 30345906
PLoS Comput Biol. 2013;9(8):e1003118
pubmed: 23950696
Nat Biotechnol. 2017 Oct 11;35(10):908-911
pubmed: 29020005
Nat Biotechnol. 2010 May;28(5):511-5
pubmed: 20436464
Clin Cancer Res. 2008 Aug 15;14(16):5158-65
pubmed: 18698033
Ann Oncol. 2014 Mar;25(3):611-618
pubmed: 24401929
Nat Med. 2018 Jul;24(7):986-993
pubmed: 29942092
Oncoimmunology. 2019 Jun 24;8(9):e1624130
pubmed: 31428522
Ann Oncol. 2014 Aug;25(8):1544-50
pubmed: 24608200
Nat Commun. 2016 May 10;7:11479
pubmed: 27161491
J Clin Oncol. 2010 Jan 1;28(1):105-13
pubmed: 19917869
J Clin Oncol. 2016 Jul 20;34(21):2460-7
pubmed: 27138582
Breast Cancer Res Treat. 2012 Apr;132(3):793-805
pubmed: 21562709
J Clin Oncol. 2013 Mar 1;31(7):860-7
pubmed: 23341518
Bioinformatics. 2011 Jun 15;27(12):1739-40
pubmed: 21546393
Clin Cancer Res. 2014 Jul 15;20(14):3818-29
pubmed: 24916698
Br J Surg. 2018 Jan;105(2):e158-e168
pubmed: 29341157
Genome Med. 2015 Feb 02;7(1):20
pubmed: 25722745
Ann Oncol. 2014 Aug;25(8):1536-43
pubmed: 24915873
Nat Med. 2008 May;14(5):518-27
pubmed: 18438415
Nature. 2000 Aug 17;406(6797):747-52
pubmed: 10963602
Nature. 2016 May 02;534(7605):47-54
pubmed: 27135926
Breast Cancer Res. 2009;11(2):R15
pubmed: 19272155
J Clin Oncol. 2012 Jun 1;30(16):1996-2004
pubmed: 22508827
JCO Precis Oncol. 2018 Mar 09;2:
pubmed: 32913985
Cancer Discov. 2011 Jun;1(1):54-67
pubmed: 22039576
Breast Cancer Res. 2011 Oct 06;13(5):R97
pubmed: 21978456
Cancer Res. 1996 Oct 15;56(20):4625-9
pubmed: 8840975
Breast Cancer Res Treat. 2010 Oct;123(3):725-31
pubmed: 20020197
J Clin Oncol. 2010 Oct 1;28(28):4316-23
pubmed: 20805453
J Clin Oncol. 2015 Mar 1;33(7):701-8
pubmed: 25605861
J Clin Oncol. 2009 Mar 10;27(8):1160-7
pubmed: 19204204
Breast Cancer Res Treat. 2012 Apr;132(2):545-53
pubmed: 21671016
NPJ Breast Cancer. 2020 Jul 6;6:28
pubmed: 32656317
Lancet Oncol. 2018 Jan;19(1):40-50
pubmed: 29233559
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Breast Cancer Res Treat. 2011 Aug;128(3):703-711
pubmed: 20842526
Genome Biol. 2007;8(8):R157
pubmed: 17683518
Genome Biol. 2011;12(3):R22
pubmed: 21410973